The study, published by the American Academy of Child & Adolescent Psychiatry in its journal, JAACAP, actually found that paroxetine (Paxil) was neither safe nor effective. Internal documents later showed that GSK hired a PR firm to ghostwrite the article, cherry-picking data and recruiting 20 co-authors to lend credibility. The company then used the paper to market Paxil to doctors. |